GlassScriptPhysician profile
Joey Levy
NPI 1346877099
$4,374.76
in general payments reported to CMS, 2019-2025
18 companies · $3,019 in 2025
The $3,019 reported for 2025 was more than what 90% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,356 · 2025: $3,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,097 · Travel and Lodging: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,096.64 |
| Travel and Lodging | $278.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,385.58 | 2024-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept Rf Probe |
| Saluda Medical Americas, INC. | $755.82 | 2025 | Evoke |
| Abbvie INC. | $696.74 | 2024-2025 | |
| Spr Therapeutics, INC | $483.51 | 2024-2025 | Sprint Pns System |
| Si-Bone, INC. | $238.74 | 2024-2025 | |
| Nalu Medical, INC. | $184.15 | 2025 | Nalu Neurostimulation System |
| Pfizer INC. | $103.65 | 2025 | |
| Spinal Simplicity, LLC | $101.74 | 2025 | Ha Minuteman G3-R |
| Vertex Pharmaceuticals Incorporated | $96.58 | 2024-2025 | |
| Trice Medical, INC. | $76.56 | 2025 | |
| Lilly USA, LLC | $75.46 | 2024-2025 | Emgality |
| Scilex Pharmaceuticals INC. | $39.25 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $34.89 | 2024 | Dysport |
| Nevro Corp. | $26.20 | 2024 | Senza |
| Pacira Pharmaceuticals Incorporated | $23.46 | 2024 | Exparel, Iovera, Zilretta |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $22.95 | 2025 | Qutenza |
| Mml US, INC. | $14.92 | 2025 | Reactiv8 |
| Collegium Pharmaceutical, INC. | $14.56 | 2024 | Belbuca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joey Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.